InsiderClue
Insiders · Profile

COLES N ANTHONY

Director at Regeneron Pharmaceuticals · Director at McKesson. Filing since 31 Aug 2018. CIK 0001197018

REGN Regeneron Pharmaceuticals Director · 6 trades MCK McKesson Corporation Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
REGN Regeneron Pharmaceuticals
28 Dec 2022
Director
Sold, plan not stated
5,758
$4.11M
84.0%
REGN Regeneron Pharmaceuticals
6 Sep 2022
Director
Sold, plan not stated
6,000
$3.49M
84.6%
REGN Regeneron Pharmaceuticals
15 Sep 2021
Director
Sold, plan not stated
11,948
$7.87M
93.0%
REGN Regeneron Pharmaceuticals
18 Aug 2021
Director
Sold, plan not stated
5,100
$3.32M
85.0%
REGN Regeneron Pharmaceuticals
17 Aug 2021
Director
Sold, plan not stated
900
$585.00K
49.9%
REGN Regeneron Pharmaceuticals
13 Aug 2021
Director
Sold, plan not stated
2,000
$1.25M
68.9%
MCK McKesson Corporation
17 Aug 2020
Director
Sold, plan not stated
2,453
$384.56K
100%
MCK McKesson Corporation
31 Aug 2018
Director
Sold, plan not stated
1,350
$173.73K
100%
8 decisions on file.